TY - JOUR
T1 - All-cause and cause-specific mortality from restrictive and obstructive spirometric patterns in Chinese adults with and without dyspnea
T2 - Guangzhou Biobank Cohort Study
AU - Pan, Jing
AU - Adab, Peymane
AU - Jiang, Chao Qiang
AU - Zhang, Wei Sen
AU - Zhu, Feng
AU - Jin, Ya Li
AU - Thomas, G. Neil
AU - Lam, Tai Hing
N1 - Publisher Copyright:
© 2019
PY - 2019/5
Y1 - 2019/5
N2 - Objective: To study whether abnormal spirometric patterns were associated with differential mortality in Chinese adults with and without dyspnea. Methods: Guangzhou Biobank Cohort Study (GBCS) participants were classified by spirometric patterns and presence of dyspnea into 6 groups: normal spirometry (NS), restriction on spirometry (ROS) and airflow obstruction (AO), each with and without dyspnea. Adjusted hazard ratios (aHRs) were calculated for mortality using Cox models. Results: Among 16777 subjects, 1595 (9.5%) had ROS, 1036 (6.2%) had AO and 1009 (6.0%) had dyspnea. A total of 1993 deaths (11.9%) occurred during 11-year follow-up. Using NS without dyspnea as reference, NS with dyspnea was significantly associated with increased cardiovascular mortality risk (aHRs 1.61 (95% confidence interval (CI) 1.18–2.19); ROS with and without dyspnea were associated with increased risks of all-cause (aHRs 1.46 (95% CI 1.28–1.66) and 1.81 (95% CI 1.33–2.47)) and cardiovascular mortality (aHRs 1.89 (95% CI 1.55–2.31) and 1.85 (95% CI 1.12–3.03)), but not of lung cancer mortality (aHRs 1.33 (95% CI 0.91–1.94) and 1.35 (95% CI 0.49–3.70)); AO with and without dyspnea were associated with increased risks of all-cause (aHRs 1.59 (95% CI 1.36–1.86) and 2.36 (95% CI 1.77–3.15)), cardiovascular (aHRs 1.43 (95% CI 1.08–1.90) and 1.61 (95% CI 0.91–2.82)) and lung cancer mortality (aHRs 1.91 (95% CI 1.29–2.84) and 3.01 (95% CI 1.46–6.23)). These associations did not vary by sex or smoking status (all P-values for interaction >0.05). Conclusion: Both ROS and AO, with and without dyspnea, were associated with increased all-cause and cardiovascular disease mortality. The increased risk of all-cause was greater and that of cardiovascular mortality was lower for AO than ROS. AO showed significantly increased risk of lung cancer but ROS did not. (272 words).
AB - Objective: To study whether abnormal spirometric patterns were associated with differential mortality in Chinese adults with and without dyspnea. Methods: Guangzhou Biobank Cohort Study (GBCS) participants were classified by spirometric patterns and presence of dyspnea into 6 groups: normal spirometry (NS), restriction on spirometry (ROS) and airflow obstruction (AO), each with and without dyspnea. Adjusted hazard ratios (aHRs) were calculated for mortality using Cox models. Results: Among 16777 subjects, 1595 (9.5%) had ROS, 1036 (6.2%) had AO and 1009 (6.0%) had dyspnea. A total of 1993 deaths (11.9%) occurred during 11-year follow-up. Using NS without dyspnea as reference, NS with dyspnea was significantly associated with increased cardiovascular mortality risk (aHRs 1.61 (95% confidence interval (CI) 1.18–2.19); ROS with and without dyspnea were associated with increased risks of all-cause (aHRs 1.46 (95% CI 1.28–1.66) and 1.81 (95% CI 1.33–2.47)) and cardiovascular mortality (aHRs 1.89 (95% CI 1.55–2.31) and 1.85 (95% CI 1.12–3.03)), but not of lung cancer mortality (aHRs 1.33 (95% CI 0.91–1.94) and 1.35 (95% CI 0.49–3.70)); AO with and without dyspnea were associated with increased risks of all-cause (aHRs 1.59 (95% CI 1.36–1.86) and 2.36 (95% CI 1.77–3.15)), cardiovascular (aHRs 1.43 (95% CI 1.08–1.90) and 1.61 (95% CI 0.91–2.82)) and lung cancer mortality (aHRs 1.91 (95% CI 1.29–2.84) and 3.01 (95% CI 1.46–6.23)). These associations did not vary by sex or smoking status (all P-values for interaction >0.05). Conclusion: Both ROS and AO, with and without dyspnea, were associated with increased all-cause and cardiovascular disease mortality. The increased risk of all-cause was greater and that of cardiovascular mortality was lower for AO than ROS. AO showed significantly increased risk of lung cancer but ROS did not. (272 words).
KW - Airflow obstruction
KW - Dyspnea
KW - Mortality
KW - Restriction on spirometry
UR - http://www.scopus.com/inward/record.url?scp=85063966300&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063966300&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2019.04.002
DO - 10.1016/j.rmed.2019.04.002
M3 - Article
C2 - 31047120
AN - SCOPUS:85063966300
SN - 0954-6111
VL - 151
SP - 66
EP - 80
JO - Respiratory Medicine
JF - Respiratory Medicine
ER -